23andMe is one of the most well-known consumer genetic DNA testing companies focusing on health and ancestry DNA testing.
Founded in 2006 by Anne Wojcicki, along with Linda Avey and Paul Cusenza, the mission of the company is to help people access, understand and benefit from the human genome.
Wojcicki built the world’s biggest genetic research database, and booked an estimated $475 million in annual sales, by selling 10 million consumers 23andMe genetic test kits. 23andMe earns most of its revenue by selling at-home DNA testing kits and selling consumer genetic databases to various healthcare organizations.
The at-home genetic testing kit company went public in Jun 2021, through a merger with a Richard Branson SPAC, VG Acquisition Corp., in a deal that raised near-$600 million and valued 23andMe at $3.5 billion.
2021 • Public
23andMe offers DNA testing with the comprehensive ancestry breakdown, personalized health insights and more.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!